期刊文献+

P73基因在喉鳞癌中的表达及其临床意义 被引量:1

Expression of P73 gene of laryngeal squamous cell carcinoma and its clinical significance
下载PDF
导出
摘要 目的 探讨P73基因在喉鳞癌中的表达。方法 用原位杂交方法检测 4 9例喉鳞癌组织、19例声带息肉、12例癌旁组织及 8例非典型增生组织中P73的表达。结果 喉鳞癌组织P73阳性表达 2 6例定位于胞浆 ,9例定位于腺体 ,5例定位于胞核 ,9例未表达。P73阳性表达率在喉鳞癌组织、声带息肉、癌旁组织及非典型增生组织中分别为 5 3.0 6 % (2 6 / 4 9) ,36 .84 % (7/ 19) ,4 1.6 7% (5 / 12 ) ,37.5 % (3/ 8) ,P73与喉鳞癌的临床分型、分期无相关性。结论 P73基因可能并非喉癌癌变过程中的靶基因 ,在喉癌的发生发展中可能不发挥重要作用。 Objective To explore the correlation between the gene P73 and the laryngeal squamous cell carcinoma (LSCC). Methods The genetic expression of P73 in 49 cases of LSCC, 19 cases of vocal cord polyp, 12 cases of paracancerous tissue, and 8 cases of nontypical hyperplasia tissue were examined by insitu hybridization histochemical method. Results The positive genetic expression of P73 in 26 cases was located in cytoplasm, 9 cases in gland, 5 cases in nucleus, and 9 cases not expressed. The positive expression rates of P73 in LSCC tissues, polyps of the vocal cord tissues, paracancerous tissues, and nontypical hyperplasis tissues were 53.06% (26/49), 36.84% (7/19), 41.67% (5/12) and 37.5% (3/8) respectively(P> 0.05 ). The gene P73 was not correlated with the clinical stages and clinical typing of LSCC. Conclusion The gene P73 might not be a target gene in laryngeal carcinogenesis and not play a major role in development of LSCC.
出处 《中国耳鼻咽喉颅底外科杂志》 CAS 2004年第1期5-7,T001,共4页 Chinese Journal of Otorhinolaryngology-skull Base Surgery
关键词 喉肿瘤/遗传学 鳞癌 鳞状细胞/遗传学 基因P73 基因表达 Laryngeal neoplasms/genet Carcinoma squamous cell/genet Genes,P73 Gene expression
  • 相关文献

参考文献8

  • 1[1]Kaghad M, Bonnet H, Yang A, et al. Monoallelically expressed gene related to p53 at 1p36, a region frequently deleted in neuroblastoma and other human cancer[J]. Cell, 1997, 90(4): 809-819.
  • 2[2]Dickman S. First p53 relative may be a new tumor suppressor[J]. Science, 1997, 277(5332): 1605-1606.
  • 3[3]Vincenzon De Laureniz, Antonio Costanzo, Daniela Barcaroli, et al. Two new P73 splice variants, γ and δ, with different transcriptional activity[J]. J Exp Med, 188(14): 1763-1768.
  • 4[4]Marin MC, Jost CA, Decaprio JA, et al. Viral oncoproteins discriminate between p53 and the p53 homolog P73[J]. Mol Cell Biol, 1998, 18(26): 6316-6324.
  • 5[5]Jost C, Marin M, Kaelin WG, et al. P73 is a human p53-related protein that can induce apoptosis [J]. Nature, 1997, 389(2): 191-194.
  • 6[6]Kovalev S, Marchenko N, Swendman S, et al. Expression level, allelix origin and mutation analysis of the P73 gene in neuroblastoma tumors and cell lines[J]. Cell Growth Differ, 1998, 9(4): 897-902.
  • 7[7]SunaharaM, IchimiyaS, NimuraY, et al. Mutational analysis of the P73 gene localized at chromosome 1p36.33 in colorectal carcinomas[J]. Int J Oncol, 1998, 13(2): 319-323.
  • 8[8]Mai M, Yokomizo A, Qian C, et al. Activation of P73 silent allele in lung cancer[J]. Cancer Res, 1998, 58(11): 2347-2351.

同被引文献11

  • 1李俊,江孝清,周绪红.p73和PCNA的表达与喉鳞状细胞癌的预后[J].临床耳鼻咽喉科杂志,2005,19(24):1121-1124. 被引量:9
  • 2葛晖,王益民,曹延延,张秀凤,李琰,郭炜,王娜,张健慧.p73基因多态性与食管癌、贲门癌遗传易感性的关系[J].癌症,2006,25(11):1351-1355. 被引量:5
  • 3Kaghad M, Bonnet H, Yang A, et al. Monoallelically expressed gene related to p53 at lp36, a region frequently deleted in neuroblastoma and other human cancers[J]. Cell, 1997, 90(4) : 809-819.
  • 4Fillippovich I, Sorokina N, Gatei M, et al. Transactivation-deficient p73alpha (p73Deltaexon2) inhibits apoptosis and competes with p53 [J]. Oncogene, 2001, 20(4): 514-522.
  • 5Grob TJ, Fey MF, Tobler A. The two faces of p73[J]. Cell Death Dif- fer, 2002, 9(3): 229-230.
  • 6Nijhara R, Jana SS, Goswami SK, et al. An internal segment (residues 58-119) of the hepatitis B virus X protein is sufficient to activate MAP kinase pathways in mouse liver[J]. FEBS Lett, 2001, 504(1-2) : 59-64.
  • 7Li G, Sturgis EM, Wang LE, et al. Association of a p73 exon2 G4C 14-to-A4T14 polymorphism with risk of squamous Cell carcinoma of the head and neck[J]. Carcinogenesis ,2004, 25 (10) : 1911 - 1916.
  • 8Uramoto H, Sugio K, Oyama T, et al. Expression of DeltaNp73 predicts poor prognosis in lung cancer[J]. Clin Cancer Res, 2004, 10 (20) : 6905-6911.
  • 9Concin N, Becker K, Slade N, et al. Transdominant DeltaTAp73 iso- forms are frequently up-regulated in ovarian cancer. Evidence for their role as epigenetic p53 inhibitors in vivo[J]. Cancer Res, 2004, 64(7) : 2449-2460.
  • 10Muller M, Schilling T, Sayan AE, et al. TAp73/Deha Np73 influ-ences apoptotie response, ehemosensitivity and prognosis in hepato-cellular carcinoma[J]. Cell Death Differ, 2005, 12(12) : 1564-1577.

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部